A Study to Learn About the Safety and Immune Response of 20vPnC in Adults in India.
NCT05875727
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
405
Enrollment
INDUSTRY
Sponsor class
Conditions
Pneumococcal Disease
Interventions
BIOLOGICAL:
20-valent pneumococcal conjugate vaccine
Sponsor
Pfizer